Pathological pulmonary artery smooth muscle cell (PASMC) proliferation contributes to pulmonary
vascular remodeling in pulmonary hypertensive diseases associated with
hypoxia. Both the
hypoxia-inducible factor (HIF) and
phosphatidylinositol 3-kinase (PI3K)/
serine/threonine kinase (Akt) pathways have been implicated in
hypoxia-induced PASMC proliferation.
Thioredoxin-1 (Trx1) is a ubiquitously expressed
protein that is involved in redox-dependent signaling via HIF and PI3K-Akt in
cancer. The role of Trx1 in PASMC proliferation has not been elucidated. The present studies tested the hypothesis that Trx1 regulates
hypoxia-induced PASMC proliferation via HIF and/or PI3K- and Akt-dependent mechanisms. Following exposure to chronic
hypoxia, our data indicate that Trx1 activity is increased in adult murine lungs. Furthermore,
hypoxia-induced increases in cellular proliferation are correlated with increased Trx1 expression, HIF activation, and Akt activation in cultured human PASMC. Both
small-interfering RNA-mediated knockdown and pharmacological Trx1 inhibition attenuated
hypoxia-induced PASMC proliferation, HIF activation, and Akt activation. While Trx1 knockdown suppressed
hypoxia-induced PI3K-Akt activation in PASMC, PI3K-Akt inhibition prevented
hypoxia-induced proliferation but had no effect on
hypoxia-induced increases in Trx1 or HIF activation. Thus, our findings indicate that Trx1 contributes to
hypoxia-induced PASMC proliferation by modulating HIF activation and subsequent PI3K-Akt activation. These novel data suggest that Trx1 might represent a novel therapeutic target to prevent hypoxic PASMC proliferation.